Cognios Beta Neutral Large Cap Fund’s Vertex Pharmaceuticals VRTX Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$544K	Sell	1,302 -286	-18%	-$121K	0.71%	41
2023 Q4	$646K	Sell	1,588 -165	-9%	-$61K	0.84%	26
2023 Q3	$610K	Sell	1,753 -532	-23%	-$186K	0.79%	39
2023 Q2	$804K	Sell	2,285 -1,229	-35%	-$414K	0.93%	29
2023 Q1	$1.1M	Buy	3,514 +4	+0.1%	+$1.2K	1.04%	22
2022 Q4	$1.01M	Buy	+3,510	New	+$1.07M	0.97%	34

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cognios Beta Neutral Large Cap Fund's VRTX Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its Vertex Pharmaceuticals (VRTX) stake by 18% in Q1 2024, selling an estimated $121K and leaving 1,302 shares worth $544K. The position accounts for 0.71% of the portfolio, ranked #41.

Cognios Beta Neutral Large Cap Fund first reported a position in VRTX in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.1M in Q1 2023. 1,494 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

Cognios Beta Neutral Large Cap Fund held 1,302 shares of Vertex Pharmaceuticals worth $544K as of Q1 2024.
Cognios Beta Neutral Large Cap Fund sold 286 Vertex Pharmaceuticals shares in Q1 2024, an estimated $121K.
Vertex Pharmaceuticals made up 0.71% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #41 holding.
Cognios Beta Neutral Large Cap Fund first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 6 quarters since.
Cognios Beta Neutral Large Cap Fund's Vertex Pharmaceuticals position peaked at $1.1M in Q1 2023.
1,494 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.